248 related articles for article (PubMed ID: 29669520)
1. Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis.
Chu D; Wu J; Wang K; Zhao M; Wang C; Li L; Guo R
BMC Cancer; 2018 Apr; 18(1):438. PubMed ID: 29669520
[TBL] [Abstract][Full Text] [Related]
2. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
Xie H; Li M; Zheng Y
Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of metformin treatment in endometrial cancer: a meta-analysis.
Gong H; Chen Y; Zhou D
Pharmazie; 2020 Aug; 75(8):401-406. PubMed ID: 32758341
[No Abstract] [Full Text] [Related]
4. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
[TBL] [Abstract][Full Text] [Related]
6. The evolving role of targeted metformin administration for the prevention and treatment of endometrial cancer: A systematic review and meta-analysis of randomized controlled trials.
Prodromidou A; Lekka S; Fotiou A; Psomiadou V; Iavazzo C
J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102164. PubMed ID: 33992830
[TBL] [Abstract][Full Text] [Related]
7. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts.
Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC
Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
Tian J; Liang Y; Qu P
Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
[TBL] [Abstract][Full Text] [Related]
9. Metformin use and endometrial cancer survival.
Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Frimer M; Conroy E; Goldberg GL; Einstein MH
Gynecol Oncol; 2014 Jan; 132(1):236-40. PubMed ID: 24189334
[TBL] [Abstract][Full Text] [Related]
10. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis.
Chae-Kim J; Garg G; Gavrilova-Jordan L; Blake LE; Kim TT; Wu Q; Hayslip CC
Int J Gynecol Cancer; 2021 Dec; 31(12):1499-1505. PubMed ID: 34785524
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
14. Metformin and the risk of endometrial cancer: a population-based cohort study.
Ko EM; Stürmer T; Hong JL; Castillo WC; Bae-Jump V; Funk MJ
Gynecol Oncol; 2015 Feb; 136(2):341-7. PubMed ID: 25499603
[TBL] [Abstract][Full Text] [Related]
15. The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis.
He K; Hu H; Ye S; Wang H; Cui R; Yi L
Sci Rep; 2019 Feb; 9(1):2218. PubMed ID: 30778081
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
Zhang ZJ; Li S
Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis.
Jumaah AS; Al-Haddad HS; McAllister KA; Yasseen AA
PLoS One; 2022; 17(2):e0263585. PubMed ID: 35139130
[TBL] [Abstract][Full Text] [Related]
18. Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer.
Yao K; Zheng H; Li T
Front Oncol; 2022; 12():942380. PubMed ID: 35898873
[TBL] [Abstract][Full Text] [Related]
19. Effects of Metformin on Risk and Prognosis of Biliary Tract Cancer: A Systematic Review and Meta-Analysis.
Chen J; Jin H; Zhou H; Liu K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837499
[No Abstract] [Full Text] [Related]
20. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
Deng Y; Wang J; Li W; Xiong W; Wang X
J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]